For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of CME Group Inc (NASDAQ: CME) was $262.45 for the day, down -1.57% from the previous closing price of $266.64. In other words, the price has decreased by -$1.57 from its previous closing price. On the day, 1.85 million shares were traded. CME stock price reached its highest trading level at $267.3577 during the session, while it also had its lowest trading level at $262.22.
Ratios:
Our analysis of CME’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 37.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 25, 2025, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $300.
UBS Downgraded its Buy to Neutral on July 24, 2025, while the target price for the stock was maintained at $305.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 30 ’25 when SHEPARD WILLIAM R bought 251 shares for $278.37 per share. The transaction valued at 69,929 led to the insider holds 258,710 shares of the business.
SHEPARD WILLIAM R bought 11 shares of CME for $3,079 on Dec 30 ’25. The Director now owns 2,477 shares after completing the transaction at $278.37 per share. On Dec 11 ’25, another insider, DUFFY TERRENCE A, who serves as the Chairman and CEO of the company, sold 25,000 shares for $269.55 each. As a result, the insider received 6,738,815 and left with 65,804 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 94639415296 and an Enterprise Value of 95838912512. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.44, and their Forward P/E ratio for the next fiscal year is 22.55. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.03 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 15.01 whereas that against EBITDA is 21.325.
Stock Price History:
The Beta on a monthly basis for CME is 0.28, which has changed by 0.1438222 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $225.46. The 50-Day Moving Average of the stock is -3.91%, while the 200-Day Moving Average is calculated to be -3.38%.
Shares Statistics:
CME traded an average of 1.85M shares per day over the past three months and 1559020 shares per day over the past ten days. A total of 359.85M shares are outstanding, with a floating share count of 359.08M. Insiders hold about 0.42% of the company’s shares, while institutions hold 91.03% stake in the company. Shares short for CME as of 1765756800 were 6158003 with a Short Ratio of 3.34, compared to 1763078400 on 5410273. Therefore, it implies a Short% of Shares Outstanding of 6158003 and a Short% of Float of 1.71.
Dividends & Splits
With its trailing 12-month dividend rate of 4.9, CME has a forward annual dividend rate of 5.00. Against a Trailing Annual Dividend Yield of 0.018376837. The stock’s 5-year Average Dividend Yield is 3.45. The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-12-12 with an ex-dividend date of 2025-12-12. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
A detailed examination of CME Group Inc (CME) is currently in progress, with 12.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $2.94, with high estimates of $3.11 and low estimates of $2.76.
Analysts are recommending an EPS of between $11.24 and $10.98 for the fiscal current year, implying an average EPS of $11.17. EPS for the following year is $11.65, with 15.0 analysts recommending between $12.25 and $11.15.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 7 analysts. It ranges from a high estimate of $1.68B to a low estimate of $1.57B. As of. The current estimate, CME Group Inc’s year-ago sales were $1.53BFor the next quarter, 7 analysts are estimating revenue of $1.7B. There is a high estimate of $1.75B for the next quarter, whereas the lowest estimate is $1.63B.
A total of 12 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.62B, while the lowest revenue estimate was $6.4B, resulting in an average revenue estimate of $6.52B. In the same quarter a year ago, actual revenue was $6.13BBased on 12 analysts’ estimates, the company’s revenue will be $6.82B in the next fiscal year. The high estimate is $7.11B and the low estimate is $6.57B.
